Skip to main content
Equibles

PPBT · Purple Biotech Ltd. · Investor Relations

Track PPBT — free

Use PPBT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PPBT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.56 +0.07 (+4.70%) At close · Nov 12
Rebalance outlook locked
Market Cap
$2.54M
Shares
1.63M
Volume · Nov 12 67.46K Avg daily vol (3M) 1.24M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-20 14:00 UTC Purple Biotech to Present IM1240 in a Plenary Oral Session at the 38th EORTC-NCI-AACR Symposium on November 20, 2026 at 15:00 CET in Barcelona, Spain. Event

Past events

Date Event Type
2025-04-07 Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025 Conference
2024-07-11 Purple Biotech to host a virtual KOL event on July 11, 2024, to discuss positive interim results from the phase 2 pancreatic cancer study with CM24. Watch here. Event
2024-06-04 Purple Biotech will present data from the Randomized Phase 2 CM24 Pancreatic Cancer Study in a Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting which takes place May 31 – June 4, 2024 in Chicago, Illinois. Presentation
2024-06-04 Purple Biotech will present data from the Randomized Phase 2 CM24 Pancreatic Cancer Study in a Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting which takes place May 31 - June 4, 2024 in Chicago, Illinois. Presentation
2023-04-20 Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference on April 20, 2023. Conference
2023-03-20 Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland. Event
2023-02-06 Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”. Conference
2023-01-09 Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023 Event
2022-11-15 Purple Biotech to participate and Present at the Jefferies London Healthcare Conference Conference
2022-11-14 Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis Conference
2022-11-08 Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. - Click here to replay Event
2022-06-05 Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022 annual meeting Shareholder meeting
2022-04-08 Purple Biotech to present at the AACR annual meeting 2022 Shareholder meeting
2021-08-09 Purple Biotech to participate in a Fireside Chat at BTIG Virtual Biotechnology Conference Conference
2021-06-04 Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting Shareholder meeting
2021-06-04 Purple Biotech to Present at the Jefferies Virtual Healthcare Conference Conference
2021-01-20 Purple Biotech to Present at the B. Riley Oncology Investor Conference Conference

Source: https://purple-biotech.com/investors/

Key facts CIK 1614744 CUSIP 74638P307 13F (30d) 8 filings 8 filers Visit website Investor relations